The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Vet. Sci.
Sec. Veterinary Dentistry and Oromaxillofacial Surgery
Volume 11 - 2024 |
doi: 10.3389/fvets.2024.1479363
This article is part of the Research Topic Recent Advances in Oral Medicine in Dogs and Cats View all 4 articles
CLINICAL AND IMMUNOHISTOCHEMICAL MANIFESTATIONS OF SUSPECTED SJOGREN'S DISEASE IN A DOG
Provisionally accepted- 1 William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, United States
- 2 Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, United States
- 3 Department of Ophthalmology and Vision Science, School of Medicine, University of California, Davis, Davis, California, United States
- 4 Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, United States
- 5 Helen Diller Family Comprehensive Cancer Center, Medical Center, University of California, San Francisco, San Francisco, California, United States
- 6 Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, San Francisco, United States
- 7 Radiation Oncology Clinic, Medical Center, University of California, San Francisco, San Francisco, United States
- 8 Departments of Pathology and Laboratory Medicine, Medical Center, University of California, San Francisco, San Francisco, United States
- 9 Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, California, United States
Sjogren's disease, well-described in people, is rarely identified in veterinary species. In people, Sjogren's disease is one of the most common systemic autoimmune disorders with an incidence of 0.5% in the female population. The hallmark histopathologic finding of primary Sjogren's disease is lymphomononuclear cell infiltrates aggregating as periductal infiltrate in salivary glands. Sjogren'slike disease has been reported in a domestic shorthair cat and golden retriever dog. However, both lacked positive antinuclear antibody (ANA) titers and the dog showed no clinical evidence of dry eye disease. The following case report describes the clinical and immunohistochemical findings suggestive of Sjogren's disease in a 3-year-old spayed female German shepherd cross that was presented for medically refractory absolute dry eye, xerostomia confirmed with oral atropine response tests, and bilateral mandibular salivary gland enlargement. Routine topical lacrostimulants, anti-inflammatories, heterologous serum, ocular lubrication, and oral pilocarpine failed to improve clinical signs or tear production. The ANA titer at 1:160 was interpreted as positive, while the complete blood count and serum biochemistry panels were unremarkable. Ultrasound revealed bilateral moderately enlarged mandibular salivary glands with a hypoechoic, mottled echotexture consistent with sialoadenitis and regional lymphadenomegaly; thoracic radiography and abdominal ultrasonography were normal. In vivo confocal microscopy and spectral-domain optical coherence tomography of the cornea confirmed lipid keratopathy presumably secondary to corneal desiccation and steroid administration. Salivary gland histopathological and immunohistochemical analyses supported an immune-mediated etiology. Approximately 60% of the salivary section contained inflammatory cells replacing the glandular structure with a focus score of 12. Immunohistochemical markers CD3, CD204, CD79a, and CD20 were evaluated. The inflammatory infiltrate was a mixture of T-cells and macrophages with rare individual immunoreactive B-cells. CD3 and CD4+ T-cells were confirmed using immunohistochemistry and quantitative PCR, respectively. Clinical signs including ocular discharge and mandibular salivary gland enlargement improved following oral immunomodulatory therapy with prednisone (1 mg/kg/d, tapered over 2 months) and long-term leflunomide (2 mg/kg/d). Ocular discomfort improved decreasing the need for topical lubricants; however, tear production failed to improve likely due to lacrimal gland atrophy. The aim of this report is to increase awareness of Sjogren's disease in dogs and interpret the pathology involved.
Keywords: Xerostomia, sicca, canine, Sjogren's disease, dry eye, Keratoconjunctivitis Sicca
Received: 12 Aug 2024; Accepted: 04 Nov 2024.
Copyright: Ā© 2024 Story, Thomasy, Randolph, Vincek, Martins, Mills, Dear, Johnson, Jordan, Goldschmidt and Vapniarsky. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Natalia Vapniarsky, Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, 95616, California, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.